For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Vicore Pharma Ab

USPTO Granted Patents = 18

% Expired Patents = 27.8

EPO Patents = 9

Trademarks = 4

Forward Citations = 20

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Anders Rudolf Hallberg (7 out of 9 patents)

Mathias Alterman (5 out of 8 patents)

Carl-Johan Dalsgaard (4 out of 6 patents)

4. Rohit Batta (4 out of 4 patents)

5. Ola Camber (4 out of 4 patents)

6. Bengt Ohlsson (3 out of 6 patents)

7. Tomas Fex (3 out of 4 patents)

8. Xiongyu Wu (2 out of 2 patents)

9. Mats Larhed (2 out of 5 patents)

10. Johan Raud (1 out of 3 patents)

11. Ulrike Steckelings (1 out of 1 patent)

12. Thomas Unger (1 out of 1 patent)

13. Murugaiah Andappan Murugaiah Subbaiah (1 out of 1 patent)

14. Christina Johansson (1 out of 1 patent)

15. Stefan Grudén (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12715864 - Process for the synthesis of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (2026-08-25),

2. 12708615 - SELECTIVE ANGIOTENSIN II RECEPTOR LIGANDS (2026-08-18),

3. 12605341 - Dry powder composition for peroral administration (2026-04-21),

4. 12441718 - Selective angiotensin II compounds (2025-10-14),

5. 12435072 - Compounds (2025-10-07),

6. 12213961 - Treatment of idiopathic pulmonary fibrosis (2025-02-04),

7. 12128029 - Treatment of idiopathic pulmonary fibrosis (2024-10-29),

8. 12121614 - Delayed release composition for peroral administration (2024-10-22),

9. 11844868 - Dry powder composition for peroral administration (2023-12-19),

10. 11819494 - Treatment of idiopathic pulmonary fibrosis (2023-11-21),

11. 11654115 - Delayed release composition for peroral administration (2023-05-23),

12. 11123329 - Use of angiotensin II type 2 receptor agonist (2021-09-21),

13. 8835471 - Use of angiotensin II agonists (2014-09-16),

14. 8357710 - Bicyclic angiotensin II agonists (2013-01-22),

15. 8124638 - Tricyclic compounds useful as angiotensin II agonists (2012-02-28),

Vicore Pharma AB is a biopharmaceutical company based in Stockholm, Sweden, focused on developing innovative therapies for rare and severe respiratory diseases. The company specializes in the research and development of novel treatments that target the underlying mechanisms of these conditions, leveraging its expertise in pharmacology and drug development. Vicore aims to address unmet medical needs through its advanced therapeutic approaches, contributing to improved patient outcomes in the field of respiratory health.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

18 Patents

#52 in Stockholm

#365 in Sweden

#34,187 in the World

Stockholm, Sweden

Vicore Pharma Ab

Forward Citations = 20

21 inventors:

Anders Rudolf Hallberg (7 out of 9 patents)

Mathias Alterman (5 out of 8 patents)

Carl-Johan Dalsgaard (4 out of 6 patents)

4. Rohit Batta (4 out of 4 patents)

5. Ola Camber (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…